| Phase 2 |
| NCT04105270 |
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A… |
Adenocarcinoma of Lung |
Recruiting |
| NCT02605421 |
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients… |
Neuroblastoma |
Recruiting |
| NCT03125642 |
Auto Stem Cell Transplant for Lymphoma Patients |
Non-Hodgkin Lymphoma |
Recruiting |
| NCT03579875 |
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders |
Fanconi Anemia |
Recruiting |
| NCT06411795 |
Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for… |
Duodenal Neoplasm |
Recruiting |
| NCT05735717 |
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies |
Hematologic Malignancy |
Recruiting |
| NCT07493538 |
MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity… |
AML |
Recruiting |
| NCT06412497 |
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and… |
Severe Aplastic Anemia |
Recruiting |
| NCT06872333 |
Allo HSCT for High Risk Hemoglobinopathies |
Graft Failure |
Recruiting |
| NCT03314974 |
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders |
Acute Leukemia |
Recruiting |
| NCT05805605 |
Allo HSCT Using RIC and PTCy for Hematological Diseases |
Acute Myelogenous Leukemia |
Recruiting |
| NCT06377540 |
MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma |
Autologous Stem Cell Transplant |
Recruiting |
| NCT06792825 |
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and… |
Follicular Lymphoma |
Recruiting |
| NCT03674411 |
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy |
Acute Myeloid Leukemia |
Active, Not Recruiting |
| NCT02171104 |
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis |
Mucopolysaccharidosis Disorders |
Active, Not Recruiting |
| NCT03642626 |
MT2017-45: CAR-T Cell Therapy for Heme Malignancies |
Acute Lymphoblastic Leukemia |
Active, Not Recruiting |
| Phase 1/2 |
| NCT07591649 |
Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT |
Relapsed Adult AML |
Recruiting |
| NCT07008638 |
Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the… |
Acute Myeloid Leukemia |
Recruiting |
| Phase 1 |
| NCT05338658 |
Study of PAT in Patients With Solid Tumor Cancers |
Metastasis |
Recruiting |
| NCT06693986 |
Adenovirus (RGDCRAdCOX2F) |
Adenocarcinoma of Pancreas |
Recruiting |
| NCT06692426 |
Trial of Cell Based Therapy for DMD |
Duchenne Muscular Dystrophy |
Recruiting |
| NCT07541573 |
GTB-5550 in Advanced Solid Tumors |
Tri-specific Killer Engager |
Recruiting |
| NCT07560865 |
First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma |
Astrocytoma |
Recruiting |
| NCT06594445 |
HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML |
Myeloid Malignancy |
Recruiting |
| NCT03998735 |
Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure |
Smokeless Tobacco |
Active, Not Recruiting |